There is an old saying that every unsustainable trend, by definition, comes to an end. The U.S. healthcare system has been on an unsustainable trajectory, consuming more and more of our national income while failing to deliver the kind of care that Americans need and deserve. But although every unsustainable trend eventually ends, how it ends is up to us.
The healthcare system has the potential to collapse under its own weight, requiring Americans to pay even more for healthcare, forcing draconian and blunt cuts in the kinds of services available, and putting high quality healthcare out of reach for the poor and the sick.
An alternative future is one in which payers pay for value, providers become more efficient and patient centered, and consumers become increasingly engaged in caring for themselves. In this future, healthcare becomes an important force for improving the health of the American public.
What will determine which path our healthcare system will take? While the fate of our healthcare system will be influenced by policymakers in Washington DC and the state capitals, it will ultimately be decided by each of us – providers and patients who are involved in the daily work of delivering and engaging in healthcare.
The journal Healthcare: The Journal of Delivery Science and Innovation is an effort to nudge us toward a better, sustainable path for our healthcare system. The mission of the journal is simple: to play a meaningful role in fostering real change in the healthcare delivery system. The journal wants to be a venue for sharing the best ideas for delivery science, payment innovation and smart use of health information technologies. The journal was conceived by Amol Navathe and Sachin Jain, who have been thinking long and hard about compelling new approaches to bring about change in the healthcare system. It took years of persistence to line up a terrific publisher, put together a top notch editorial board and recruit some of the nation’s best minds to lead individual theme areas. And it paid off handsomely. Today, June 26th, Healthcare officially launches with its premier issue, and what an issue it is.
The two introductions are short, pithy and worth reading over and over again. The first is by Don Berwick, the former Administrator of the Centers for Medicare and Medicaid Services but even more importantly (at least to me), the man who has done more to promote quality and safety than anyone in recent memory. Don frames the issues in ways that only he can, reminding us that we can have the best healthcare system in the world – we have all the pieces – but we have to learn how to put it together.
The second introduction is by Jim Kim, the President of the World Bank. Dr. Kim reminds us that while great ideas are common, great execution is priceless. Yet, as he says, too often “we have an inexplicably high tolerance for poor execution”, which compromises the quality and efficiency with which care is delivered. This kind of waste is no longer tolerable in the U.S. and is completely unaffordable elsewhere.
The rest of the journal is filled with ideas and research from some of the leading thinkers in the country. Kevin Volpp and his colleagues describe their approach to refining the way randomized control trials are conducted to improve healthcare delivery. Instead of taking years to carefully control every aspect of an evaluation in order to perfectly isolate the effect of a specific intervention (that was conceived ex ante), Volpp and colleagues offer a more flexible approach. Borrowing ideas from operations research and focusing on the notion of iterative innovation, the authors lay out a path that will allow providers and researchers to understand and improve real-life interventions without compromising scientific rigor. This is amazing work that could profoundly change the rate of innovation in healthcare delivery.
I want to highlight a few other pieces. Clese Erikson from the Association of American Medical Colleges has a terrific piece about the much discussed but poorly understood “primary care shortage” and describes ways in which new models of care delivery can help improve the productivity of the current workforce. More importantly, Clese takes on many of the arguments that people on both sides of this debate like to make (such as the potential role of health IT to make doctors more efficient) and calls for rigorous evaluations so we can have a more data-driven debate. Mike Chernew has a critically important piece about global payments, a new way of paying for healthcare that has seen important early success. Chernew points out that while such a payment approach is promising, its success and spread over the long run is by no means certain.
One of my favorite papers in this issue is by the prolific Zirui Song. Song and colleagues (including Chernew) examine the best known global payment model, the Alternative Quality Contract, in Massachusetts to look carefully at utilization of technology-intensive medical services. They find that some services which are high value, such as colonoscopies, increased under the AQC while other services of more questionable value, such as angioplasties, fell. This is exactly what we would hope to see. It is a particularly important finding because it reveals that the underlying mechanism, is that savings were primarily achieved by a shift to lower priced providers. Whether utilization of lower value services continues to decrease over time will be critical to watch.
Several more studies are worth highlighting. An excellent study by Hao Yu (with Ateev Mehrotra and John Adams) examines the reliability of utilization measures for performance profiling primary care physicians (PCPs). PCPs are being increasingly profiled by payers and labeled as “efficient” or “inefficient”. Yu and colleagues examined 11 measures that are commonly used to profile physicians and found that 7 of them have poor reliability while the other 4 are reasonably good. The implications are obvious and important: if we use unreliable measures of utilization, we will imprecisely label doctors as efficient or inefficient, making profiling efforts useless or even harmful. If payers and policymakers can use important empirical work like this, they are far more likely to be effective in their efforts to drive efficiency through physician profiling.
Tara Lagu (with Peter Lindenauer as the senior author) examines variations in spending on sepsis patients. These are among the most expensive patients in the healthcare system, with the average case costing more than $20,000. Lagu and colleagues find that while much of the variation in spending across hospitals is due to factors not easily amenable to intervention (e.g., severity of illness of the patient), one-third of the variation in spending is due to variations in practice style. Given how much we spend on sepsis each year (over $24 billion), reducing even a small part of the variation can lead to substantial savings.
Christian Terwiesch (with Kevin Volpp again) writes about the Penn medicine innovation tournament, a brilliant effort to engage the thousands of employees who work in the Penn healthcare system to submit ideas to improve their delivery system. They received over 1,700 ideas. Beyond the great ideas, the biggest benefit of the tournament might have been its effects on the culture at Penn, where the tournament made clear to employees that “their ideas and participation are valued.”
Andrew Ryan and Cheryl Damberg, who have previously written extensively about pay-for-performance (P4P), have an important summary piece about what we know about P4P and what it can tell us about future federal policy efforts in this area. Last, but not least, is an excellent interview with Mark McClellan, another former administrator of CMS (and so much more). Among other things, McClellan discusses the promise of ACOs and why he thinks they might be an important source of innovation in healthcare delivery.
So there you go – an amazing issue. Navathe and Jain deserve credit for getting the journal launched, but extra credit goes to Rachel Werner and Melinda Buntin, who co-edited the issue and put together an amazing line up of articles. The gains in healthcare quality and efficiency that could come simply from the insights in the inaugural issue are substantial. They have set the bar very high for the next issues that follow. Stay tuned.
Ashish Jha, MD, MPH is the C. Boyden Gray Associate Professor of Health Policy and Management at the Harvard School of Public Health. He blogs at An Ounce of Evidence. He is also the Senior Editor-in-Chief for Healthcare: The Journal of Delivery Science and Innovation. The first issue of this Journal was released today, June 26, 2013.
I’m thrilled to see the announcement of this journal! This post hits on a wide range of inter-related topics — each so critical for helping healthcare leaders manage the transition from volume to value, shining light on where the future is already here in some way shape or form. There’s a common misconception that innovation emerges out of thin air. In our work with healthcare organizations, we find that innovation is more frequently the result of combining and recombining existing ideas. Helping people see how the future is already playing out — in the field or inside their own organizations —inspires innovation.
We’re up for it! ; )
Seriously, we’ll be following this one closely. I think most observers would agree that the journal publishing industry is one where a little innovation wouldn’t be a bad thing. Curious to know more about what you’re doing differently ….
Great idea guys. I wish you the best in your effort. Since you seem to work with closely THCB why not accept innovation ideas from readers here? I’m assuming you’ll eventually have a web-based “open” side — assuming your publisher would ever go for it
Best Wishes on the launch of this important new Journal. I hope future issues deal with the singular issue, in my opinion, around which our US medical profession and for that matter our still young US culture can finally mature- I am of course referring to aging and death and dying in America where ,with some very notable exceptions, contemporary bio-medicine has failed miserably. I am also talking about the extreme importance of humility and the irrefutable centrality of caring over curing as the very essence of our “former” profession of medicine.
Dr. Rick Lippin